Source: NASDAQ Stocks / 10 Nov 2023 08:14:44 America/Chicago
AstraZeneca’s AZN third-quarter 2023 core earnings of 87 cents per American depositary share (ADS) beat the Zacks Consensus Estimate of 80 cents. Core earnings of $1.73 per share rose 4% year over year on a reported basis and 9% a
https://www.nasdaq.com/articles/astrazeneca-azn-beats-on-q3-earnings-sales-ups-2023-view